Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3751
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $342K | ﹤0.01% |
1,073
+3
| +0.3% | +$884 |
|
3752
SOPHiA GENETICS
SOPH
$647M
| $341K | ﹤0.01% |
69,163
+5,460
| +9% | +$26.4K |
|
3753
Espey Mfg & Electronics Corp
ESP
$187M
| $340K | ﹤0.01% |
13,477
+1,456
| +12% | +$33.7K |
|
3754
NeoVolta
NEOV
$155M
| $340K | ﹤0.01% |
288,264
| – | – |
|
3755
IZEA Worldwide
IZEA
$61.3M
| $339K | ﹤0.01% |
146,575
+1,341
| +0.9% | +$2.73K |
|
3756
US Global Investors
GROW
$38.5M
| $338K | ﹤0.01% |
121,459
| – | – |
|
3757
Sabesp
SBS
$18.7B
| $338K | ﹤0.01% |
103,419
+252
| +0.2% | +$769 |
|
3758
Cognition Therapeutics
CGTX
$96.7M
| $337K | ﹤0.01% |
185,196
+10,398
| +6% | +$21.5K |
|
3759
GDS Holdings
GDS
$6.41B
| $336K | ﹤0.01% |
50,584
| – | – |
|
3760
Comstock
LODE
$245M
| $336K | ﹤0.01% |
92,241
+2,682
| +3% | +$12.1K |
|
3761
ECARX Holdings
ECX
$432M
| $335K | ﹤0.01% |
170,906
| – | – |
|
|
LAC
3762
Lithium Americas
LAC
$1.17B
| $333K | ﹤0.01% |
49,594
+5,443
| +12% | +$28.3K |
|
3763
Protara Therapeutics
TARA
$232M
| $333K | ﹤0.01% |
82,907
+4,389
| +6% | +$14.2K |
|
3764
Kingstone Companies
KINS
$276M
| $332K | ﹤0.01% |
74,531
| – | – |
|
3765
IN8bio
INAB
$9.64M
| $331K | ﹤0.01% |
9,351
+2,704
| +41% | +$102K |
|
|
CODX
3766
Co-Diagnostics
CODX
$5.6M
| $330K | ﹤0.01% |
9,814
| – | – |
|
3767
Journey Medical
DERM
$177M
| $328K | ﹤0.01% |
89,075
+3,290
| +4% | +$14.3K |
|
|
YARW
3768
Yarrow Bioscience, Inc. Common Stock
YARW
$111M
| $328K | ﹤0.01% |
2,136
+249
| +13% | +$26.8K |
|
|
SDIG
3769
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
| $327K | ﹤0.01% |
78,708
+23,057
| +41% | +$117K |
|
3770
GEE Group
JOB
$22.5M
| $326K | ﹤0.01% |
905,764
| – | – |
|
|
EFTR
3771
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $325K | ﹤0.01% |
22,609
+6,290
| +39% | +$75.3K |
|
3772
electroCore
ECOR
$72.9M
| $325K | ﹤0.01% |
52,609
+758
| +1% | +$5.12K |
|
|
GATE
3773
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
| $324K | ﹤0.01% |
31,099
+234
| +0.8% | +$2.45K |
|
3774
LENSAR
LNSR
$74.2M
| $322K | ﹤0.01% |
90,711
+1,528
| +2% | +$6.29K |
|
|
GOOS
3775
Canada Goose Holdings
GOOS
$856M
| $320K | ﹤0.01% |
26,430
+2,019
| +8% | +$25.1K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.